1. Home
  2. IMRX vs DHAI Comparison

IMRX vs DHAI Comparison

Compare IMRX & DHAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • DHAI
  • Stock Information
  • Founded
  • IMRX 2008
  • DHAI 2007
  • Country
  • IMRX United States
  • DHAI United States
  • Employees
  • IMRX N/A
  • DHAI N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • DHAI
  • Sector
  • IMRX Health Care
  • DHAI
  • Exchange
  • IMRX Nasdaq
  • DHAI NYSE
  • Market Cap
  • IMRX 52.2M
  • DHAI 49.1M
  • IPO Year
  • IMRX 2021
  • DHAI N/A
  • Fundamental
  • Price
  • IMRX $1.87
  • DHAI $0.23
  • Analyst Decision
  • IMRX Strong Buy
  • DHAI
  • Analyst Count
  • IMRX 3
  • DHAI 0
  • Target Price
  • IMRX $15.33
  • DHAI N/A
  • AVG Volume (30 Days)
  • IMRX 240.9K
  • DHAI 662.8K
  • Earning Date
  • IMRX 05-05-2025
  • DHAI 07-14-2025
  • Dividend Yield
  • IMRX N/A
  • DHAI N/A
  • EPS Growth
  • IMRX N/A
  • DHAI N/A
  • EPS
  • IMRX N/A
  • DHAI N/A
  • Revenue
  • IMRX N/A
  • DHAI $69,573,000.00
  • Revenue This Year
  • IMRX N/A
  • DHAI N/A
  • Revenue Next Year
  • IMRX N/A
  • DHAI N/A
  • P/E Ratio
  • IMRX N/A
  • DHAI N/A
  • Revenue Growth
  • IMRX N/A
  • DHAI 5.40
  • 52 Week Low
  • IMRX $1.00
  • DHAI $0.12
  • 52 Week High
  • IMRX $3.83
  • DHAI $3.67
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 68.56
  • DHAI 51.94
  • Support Level
  • IMRX $1.58
  • DHAI $0.21
  • Resistance Level
  • IMRX $1.85
  • DHAI $0.28
  • Average True Range (ATR)
  • IMRX 0.15
  • DHAI 0.03
  • MACD
  • IMRX 0.05
  • DHAI 0.00
  • Stochastic Oscillator
  • IMRX 97.20
  • DHAI 55.05

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About DHAI DIH HOLDINGS US INC

DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.

Share on Social Networks: